At MD&M West 2025, the energy on the show floor was palpable—AI wasn’t just the buzzword of the conference, it was the battleground. From keynote stages to exhibit booths, medical device manufacturers came ready to showcase how artificial intelligence is changing the landscape of MedTech innovation. But among all the flash and hype, one comment from our CEO, Anupam Girdhar, captured a deeper truth about where the industry is really headed:
“One part that sometimes gets missed is that while a lot of companies focus on devices, on instruments, on consumables, there’s an underlying platform that’s needed to automate things. It’s one thing to develop a device—it’s another thing to develop it at mass production level, in a cost-efficient way.”
Anupam’s insight gets to the heart of a conversation we’re having every day with our customers: real transformation doesn’t happen in the concept phase—it happens in the infrastructure. The MedTech industry is no longer just designing products. We’re designing systems that need to be intelligent, scalable, and AI-ready from day one.
From Design for Manufacturing to Design for Data
Historically, the focus was on Design for Manufacturing (DFM)—ensuring a product could be reliably and cost-effectively produced. But as AI enters the mainstream of MedTech, a new paradigm is emerging: Design for Data and Design for AI. That means building products with the capability to collect, transmit, and act on data from the outset.
As Anupam put it, “Now it is Design for Data and Design for AI, so that your instruments are capable of at least spitting out that data.”
This evolution is critical because AI is only as powerful as the data it can access. For medical device companies, that means investing in the digital backbone—the data pipelines, integration strategies, and real-time feedback loops—that allow AI to do its job. Without this foundation, even the most advanced algorithms are rendered useless.
Why Data Readiness Is a Competitive Advantage
At Ascential, we’ve made intentional progress in helping clients design products and production systems that are data-ready—from day one. And the impact is real.
Imagine a high-precision instrument experiencing an unexpected spike in failure rates. In a legacy system, identifying the root cause might take weeks of manual testing and guesswork. With a data-centric platform in place, however, the device is already streaming real-time usage data. AI can detect patterns, flag anomalies, and even predict the issue before it causes a critical failure.
This isn’t just theoretical. We’re implementing these systems now—and our customers are seeing the results in improved uptime, faster root cause analysis, and smarter product iteration cycles.
Automation Is the Missing Link
But AI and data readiness alone aren’t enough. To unlock the full benefits, companies need to integrate these insights with automated manufacturing processes. That’s where Ascential shines.
We bridge the gap between engineering brilliance and scalable manufacturing by designing systems that are both intelligent and operationally robust. We don’t just build products—we build the automation, analytics, and process control systems that scale those products to market at speed and with confidence.
This is the platform approach Anupam was referring to—one that unites product design, data, and production under a single, integrated ecosystem.
Looking Ahead
AI is no longer on the horizon—it’s here. But as the medical device industry rushes to embrace its promise, the real competitive advantage will go to the companies that design for data, plan for automation, and build for scale.
At Ascential, we’re proud to lead that charge—helping the most innovative MedTech companies turn groundbreaking ideas into market-ready, intelligent systems that improve outcomes and change lives.
Let’s talk about how we can help you build your next generation of smart, scalable MedTech products.
Get started with AscentialContact Us
Related:
Medical Equipment Manufacturing: How to Scale from R&D to Full Commercialization
Navigating Uncertainty: How Medtech is Responding to Tariffs and Global Trade Disruptions
